Hanson & Doremus Investment Management Sanofi Transaction History

Hanson & Doremus Investment Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$45.75 - $52.48 $5,718 - $6,560	125 New	125 $6,000
Q3 2022 Oct 20, 2022	SELL	$37.22 - $100.5 $6,513 - $17,587	-175 Reduced 76.42%	54 $2,000
Q2 2022 Jul 19, 2022	SELL	$48.99 - $57.46 $6,123 - $7,182	-125 Reduced 35.31%	229 $11,000
Q1 2022 Apr 22, 2022	BUY	$48.48 - $53.65 $17,161 - $18,992	354 New	354 $18,000
Q4 2021 Jan 20, 2022	SELL	$47.07 - $52.35 $20,051 - $22,301	-426 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$47.89 - $53.12 $6,896 - $7,649	144 Added 51.06%	426 $20,000
Q3 2020 Oct 19, 2020	BUY	$49.47 - $53.77 $3,561 - $3,871	72 Added 34.29%	282 $14,000
Q2 2020 Jul 17, 2020	BUY	$42.91 - $52.5 $9,011 - $11,025	210 New	210 $11,000

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $120B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Hanson & Doremus Investment Management, based on Form 13F filings with the SEC.

Stay updated on Hanson & Doremus Investment Management with notifications on news.